Mirikizumab for UC: Phase 3 Data Now Published in NEJM ...Middle East

Mirikizumab manufacturer Eli Lilly, which funded the study, is hoping the drug will become the first IL-23 inhibitor to be approved in the United States for the treatment of ulcerative colitis (UC). MDedge News

Hence then, the article about mirikizumab for uc phase 3 data now published in nejm was published today ( Thursday 13/07/2023 - 04:28 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Mirikizumab for UC: Phase 3 Data Now Published in NEJM )

Also on site :

• Peter Alexander is leaving NBC after years of being passed over for top anchor jobs: source
• The Japanese Concept a Psychologist Swears by To Find Purpose in Life
• Pharmacy workers, others ratify four-year contract with Kaiser